Background: Venous leg ulcer (VLU) is among the most severe clinical manifestations of chronic venous disease (CVD) and imposes substantial burdens on both patients and society. VLU pathogenesis is closely associated with the impairment of vascular endothelial cells. In this study, tissue samples from the patients' s skins around wound at different stages of CVD were collected during operation and used to elucidate the involvement of ferroptosis in the pathogenesis of VLU. Also the potential mechanism through which Huoxue Shengji (HXSJ) decoction alleviates ferroptosis in human umbilical vein endothelial cells (HUVECs) was investigated.
Methods: During surgical procedure such as great saphenous vein high ligation and stripping surgery, matched skin tissues from the normal, hyperpigmentation (HPT), lipodermatosclerosis (LDS), and VLU regions were collected from 10 patients with VLU, and the levels of iron and glutathione peroxidase 4 (GPX4) were quantified to evaluate ferroptosis. In vitro, HUVECs were used to iron overload induction using exogenous 100 µM ferric ammonium citrate (FAC) or 100 µM hemin, or ferroptosis induction with 10 µM erastin, and treated with 10 µg/ml HXSJ decoction for 24 h. Subsequently, lipid peroxidation (LPO) damage, mitochondrial function, and key genes involved in ferroptosis were assessed.
Results: Iron deposition in the affected skin of patients with CVD gradually increased before progression to VLU and significantly decreased during the VLU stage. Moreover, GPX4 expression increased significantly in the HPT stage but was gradually suppressed with further deterioration of CVD. The in vitro results indicated that in both the iron overload and ferroptosis models, HXSJ decoction effectively upregulated the expression of nuclear factor erythroid 2-related factor 2 (Nrf2), solute carrier family 7 member 11 (SLC7A11, xCT), and GPX4, which was accompanied by the inhibition of malondialdehyde and protein carbonylation production, the alleviation of ferrous ion accumulation, and the restoration of mitochondrial function.
Conclusions: This study demonstrated that iron accumulation-mediated inactivation of GPX4 serves as a crucial mechanism in VLU formation through ferroptosis induction. Notably, the therapeutic mechanism through which HXSJ decoction alleviates ferroptosis involves Nrf2/xCT/GPX4 pathway activation and a reduction in ferrous ion accumulation. These findings may provide novel insights into VLU pathogenesis and give possible reason for developing traditional Chinese medicine therapies targeting ferroptosis and VLUs.
{"title":"Potential mechanism underlying HXSJ decoction in the treatment of venous leg ulcers: based on the association between venous leg ulcers and ferroptosis.","authors":"Sunfeng Pan, Lie Xiong, Jiakun Li, Zhenjun Wang, Yujuan Su, Gaofeng Fang, Minda Zhu, Hanqiang Shi, Jiayan Li, Zhaoyan Liu, Chunmao Han, Yanbo Shi","doi":"10.1186/s12906-025-05184-3","DOIUrl":"10.1186/s12906-025-05184-3","url":null,"abstract":"<p><strong>Background: </strong>Venous leg ulcer (VLU) is among the most severe clinical manifestations of chronic venous disease (CVD) and imposes substantial burdens on both patients and society. VLU pathogenesis is closely associated with the impairment of vascular endothelial cells. In this study, tissue samples from the patients' s skins around wound at different stages of CVD were collected during operation and used to elucidate the involvement of ferroptosis in the pathogenesis of VLU. Also the potential mechanism through which Huoxue Shengji (HXSJ) decoction alleviates ferroptosis in human umbilical vein endothelial cells (HUVECs) was investigated.</p><p><strong>Methods: </strong>During surgical procedure such as great saphenous vein high ligation and stripping surgery, matched skin tissues from the normal, hyperpigmentation (HPT), lipodermatosclerosis (LDS), and VLU regions were collected from 10 patients with VLU, and the levels of iron and glutathione peroxidase 4 (GPX4) were quantified to evaluate ferroptosis. In vitro, HUVECs were used to iron overload induction using exogenous 100 µM ferric ammonium citrate (FAC) or 100 µM hemin, or ferroptosis induction with 10 µM erastin, and treated with 10 µg/ml HXSJ decoction for 24 h. Subsequently, lipid peroxidation (LPO) damage, mitochondrial function, and key genes involved in ferroptosis were assessed.</p><p><strong>Results: </strong>Iron deposition in the affected skin of patients with CVD gradually increased before progression to VLU and significantly decreased during the VLU stage. Moreover, GPX4 expression increased significantly in the HPT stage but was gradually suppressed with further deterioration of CVD. The in vitro results indicated that in both the iron overload and ferroptosis models, HXSJ decoction effectively upregulated the expression of nuclear factor erythroid 2-related factor 2 (Nrf2), solute carrier family 7 member 11 (SLC7A11, xCT), and GPX4, which was accompanied by the inhibition of malondialdehyde and protein carbonylation production, the alleviation of ferrous ion accumulation, and the restoration of mitochondrial function.</p><p><strong>Conclusions: </strong>This study demonstrated that iron accumulation-mediated inactivation of GPX4 serves as a crucial mechanism in VLU formation through ferroptosis induction. Notably, the therapeutic mechanism through which HXSJ decoction alleviates ferroptosis involves Nrf2/xCT/GPX4 pathway activation and a reduction in ferrous ion accumulation. These findings may provide novel insights into VLU pathogenesis and give possible reason for developing traditional Chinese medicine therapies targeting ferroptosis and VLUs.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"451"},"PeriodicalIF":3.4,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12751643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145861894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-29DOI: 10.1186/s12906-025-05171-8
Azadeh Taherpour, Farshad Mirzavi, Ebrahim Shafaei, Asghar Zarban, Mehdi Shakibaie
Background: Wound healing is a complex process requiring coordinated cellular responses. Honey and silver nanoparticles (AgNPs) are well-known for their potential to heal wounds. However, there is little evidence of their combined impact on wound healing in fibroblast cells. This study aimed to investigate the combined effects of two types of honey with AgNPs on bacterial growth inhibition and wound healing in human dermal fibroblast cells.
Method: Honey samples were characterized based on phenolic content, antioxidant capacity, and protein levels. The AgNPs were synthesized and characterized by dynamic light scattering, ultraviolet-visible, transmission electron microscopy, and X-ray powder diffraction. Antibacterial activity was assessed by checkerboard assay. The effect of honey, AgNPs, and their combination on fibroblast cell viability and wound healing was evaluated. Quantitative real-time PCR was conducted to evaluate the mRNA expression of growth factors.
Results: Our results showed that Barberry honey significantly increased fibroblast cell growth, wound healing, and expression of FGF2, TGFβ1, COL1A1, and VEGFA genes compared to commercial honey. Combination of honey with AgNPs significantly increased VEGFA gene expression compared to either agent alone. Barberry honey and AgNPs also showed strong antibacterial effects individually. However, their combination had no synergistic effect.
Conclusion: These findings suggest that Barberry honey and its combination with AgNPs could serve as effective agents for promoting the fibroblast wound healing process. However, more in vitro and in vivo research is needed to investigate further mechanisms of Barberry honey alone and in combination with AgNPs in wound healing.
{"title":"Combined effects of honey and silver nanoparticles on wound healing in human dermal fibroblast cells.","authors":"Azadeh Taherpour, Farshad Mirzavi, Ebrahim Shafaei, Asghar Zarban, Mehdi Shakibaie","doi":"10.1186/s12906-025-05171-8","DOIUrl":"10.1186/s12906-025-05171-8","url":null,"abstract":"<p><strong>Background: </strong>Wound healing is a complex process requiring coordinated cellular responses. Honey and silver nanoparticles (AgNPs) are well-known for their potential to heal wounds. However, there is little evidence of their combined impact on wound healing in fibroblast cells. This study aimed to investigate the combined effects of two types of honey with AgNPs on bacterial growth inhibition and wound healing in human dermal fibroblast cells.</p><p><strong>Method: </strong>Honey samples were characterized based on phenolic content, antioxidant capacity, and protein levels. The AgNPs were synthesized and characterized by dynamic light scattering, ultraviolet-visible, transmission electron microscopy, and X-ray powder diffraction. Antibacterial activity was assessed by checkerboard assay. The effect of honey, AgNPs, and their combination on fibroblast cell viability and wound healing was evaluated. Quantitative real-time PCR was conducted to evaluate the mRNA expression of growth factors.</p><p><strong>Results: </strong>Our results showed that Barberry honey significantly increased fibroblast cell growth, wound healing, and expression of FGF2, TGFβ1, COL1A1, and VEGFA genes compared to commercial honey. Combination of honey with AgNPs significantly increased VEGFA gene expression compared to either agent alone. Barberry honey and AgNPs also showed strong antibacterial effects individually. However, their combination had no synergistic effect.</p><p><strong>Conclusion: </strong>These findings suggest that Barberry honey and its combination with AgNPs could serve as effective agents for promoting the fibroblast wound healing process. However, more in vitro and in vivo research is needed to investigate further mechanisms of Barberry honey alone and in combination with AgNPs in wound healing.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"446"},"PeriodicalIF":3.4,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12751895/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145854194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-29DOI: 10.1186/s12906-025-05226-w
Alambo K Mssusa, Godeliver Kagashe, Sheila Maregesi, Lone Holst
{"title":"Pharmacovigilance and herbal medicines safety: a cross-sectional study of healthcare professionals' knowledge, attitudes and practices in selected regions of Tanzania, 2021.","authors":"Alambo K Mssusa, Godeliver Kagashe, Sheila Maregesi, Lone Holst","doi":"10.1186/s12906-025-05226-w","DOIUrl":"10.1186/s12906-025-05226-w","url":null,"abstract":"","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":" ","pages":"37"},"PeriodicalIF":3.4,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12860113/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145854220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-29DOI: 10.1186/s12906-025-05227-9
Nada Lukkahatai, Hongyu Wang, Xinran Huang, Wanqi Chen, Hulin Wu, Jennifer Kawi, Zhiyin Yu, Constance M Johnson, Paul Christo
{"title":"Effects of auricular point acupressure on inflammatory signaling in chronic low back pain: a secondary analysis of a randomized controlled trial.","authors":"Nada Lukkahatai, Hongyu Wang, Xinran Huang, Wanqi Chen, Hulin Wu, Jennifer Kawi, Zhiyin Yu, Constance M Johnson, Paul Christo","doi":"10.1186/s12906-025-05227-9","DOIUrl":"10.1186/s12906-025-05227-9","url":null,"abstract":"","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":" ","pages":"35"},"PeriodicalIF":3.4,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12860021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145854239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The effect of probiotics on anxiety, depression, nicotine dependence, and metabolic biomarkers in smokers: a randomized clinical trial.","authors":"Nasim Sadeghi, Shahram Shams, Reyhaneh-Sadat Mirlohian, Freshteh Haerifar, Mostafa Bakhshi-Kashi, Amir Ghaderi","doi":"10.1186/s12906-025-05232-y","DOIUrl":"10.1186/s12906-025-05232-y","url":null,"abstract":"","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":" ","pages":"36"},"PeriodicalIF":3.4,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12859967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145848902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background and objective: Primary health care (PHC) systems are increasingly challenged by the rising burden of chronic diseases and the growing demand for personalized care. Persian Medicine (PM), with its constitution-based approach and rich historical foundation, holds significant potential as a complementary strategy in population health management within the PHC framework. This study aimed to explore the barriers and facilitators to integrating PM into the PHC system from the perspectives of Community Health Workers (CHWs) and Community Health Supervisors (CHSs).
Methods: A qualitative descriptive design with thematic analysis was employed. Data were collected through semi-structured interviews with 18 CHWs and CHSs in Primary Healthcare Centers (PHCs) in Tabriz, Iran. Purposive sampling with maximum variation was used to ensure diversity of perspectives. Data were analyzed using the Braun and Clarke framework with MAXQDA version 24. To ensure trustworthiness, member checking and peer debriefing were conducted by independent researchers.
Results: Five main themes emerged: (1) challenges in designing and integrating PM assessment tools into PHC; (2) structural and policy-level barriers; (3) challenges in health education and information acceptance; (4) human resource constraints and motivation; and (5) facilitating factors and participant-driven strategies. The first four themes represent barriers, while the fifth highlights strategies for successful PM integration into PHC.
Conclusion: The successful integration of PM into PHC requires a comprehensive strategy Empowering healthcare personnel, developing evidence-based protocols, improving health literacy, and fostering collaboration between PM and conventional medicine are essential steps toward achieving this goal.
{"title":"Barriers and facilitators to integrating Persian medicine into primary health care in Iran: a qualitative study from the perspective of community health workers and community health supervisors.","authors":"Reyhaneh Mostafanejad, Jafar Sadegh Tabrizi, Alireza Bagherzadeh-Karimi, Sayyedeh Mobina Izadkhah, Rahim Khodayari-Zarnaq","doi":"10.1186/s12906-025-05170-9","DOIUrl":"10.1186/s12906-025-05170-9","url":null,"abstract":"<p><strong>Background and objective: </strong>Primary health care (PHC) systems are increasingly challenged by the rising burden of chronic diseases and the growing demand for personalized care. Persian Medicine (PM), with its constitution-based approach and rich historical foundation, holds significant potential as a complementary strategy in population health management within the PHC framework. This study aimed to explore the barriers and facilitators to integrating PM into the PHC system from the perspectives of Community Health Workers (CHWs) and Community Health Supervisors (CHSs).</p><p><strong>Methods: </strong>A qualitative descriptive design with thematic analysis was employed. Data were collected through semi-structured interviews with 18 CHWs and CHSs in Primary Healthcare Centers (PHCs) in Tabriz, Iran. Purposive sampling with maximum variation was used to ensure diversity of perspectives. Data were analyzed using the Braun and Clarke framework with MAXQDA version 24. To ensure trustworthiness, member checking and peer debriefing were conducted by independent researchers.</p><p><strong>Results: </strong>Five main themes emerged: (1) challenges in designing and integrating PM assessment tools into PHC; (2) structural and policy-level barriers; (3) challenges in health education and information acceptance; (4) human resource constraints and motivation; and (5) facilitating factors and participant-driven strategies. The first four themes represent barriers, while the fifth highlights strategies for successful PM integration into PHC.</p><p><strong>Conclusion: </strong>The successful integration of PM into PHC requires a comprehensive strategy Empowering healthcare personnel, developing evidence-based protocols, improving health literacy, and fostering collaboration between PM and conventional medicine are essential steps toward achieving this goal.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"447"},"PeriodicalIF":3.4,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12751132/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145854247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-29DOI: 10.1186/s12906-025-05174-5
Bance Alimata, Rouamba Ablassé, Compaoré Moussa, Compaoré Eli, Kabré W M E Leila, Ouedraogo Noufou, Hay A Emmanuelle, Kiendrebeogo Martin, Dijoux-Franca Marie-Geneviève
{"title":"Anti-biofilm, anti-quorum sensing potential, cytotoxicity, and UPLC-UV/DAD-MS/MS/QTOF profiling of Prosopis Africana (Guill. & Perr.) Taub. leaves and stems extracts: benefits of a traditional medicine in dental care.","authors":"Bance Alimata, Rouamba Ablassé, Compaoré Moussa, Compaoré Eli, Kabré W M E Leila, Ouedraogo Noufou, Hay A Emmanuelle, Kiendrebeogo Martin, Dijoux-Franca Marie-Geneviève","doi":"10.1186/s12906-025-05174-5","DOIUrl":"10.1186/s12906-025-05174-5","url":null,"abstract":"","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"445"},"PeriodicalIF":3.4,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12752260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145854163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Background: </strong>Aflatoxin B1 (AFB1) is a common contaminant in agricultural and animal-derived products worldwide, representing a significant environmental hazard. Therefore, this study aimed to assess the anti-toxicity effects of enhanced essential oil from Melissa officinalis, through a safe carrageenan, on HT-29 and HEK-293 cells contaminated with AFB1.</p><p><strong>Methods: </strong>Seeds of M. officinalis were cultivated in plastic containers and subsequently treated with 400 ppm carrageenan during the 6-8 leaf developmental stage. Gas chromatography-mass spectrometry (GC/MS) was employed to characterize the bioactive compounds of the essential oil. The cancerous HT-29 and healthy HEK-293 cell lines were exposed to various concentrations of AFB1 (0.5-3 µg/mL), with and without carrageenan-treated M. officinalis essential oil extract at concentrations ranging from 5 to 40 µg/mL. Based on the findings from the MTT assay, 1 µg/mL of AFB1 and 10 µg/mL of the essential oil extract were selected for subsequent analyses, including flow cytometry, reactive oxygen species assessments, and RT-qPCR.</p><p><strong>Results: </strong>Flow cytometric analysis indicated that AFB1-induced necrosis in healthy HEK-293 cells (13.10%) was significantly greater than in HT-29 cancer cells (2.33%). In contrast, AFB1 elicited a greater degree of early apoptosis (14.80%) and late apoptosis (11.20%) in HT-29 cells compared to HEK-293 cells, which demonstrated 3.86% and 2.26% early and late apoptosis, respectively. A total of nine and fourteen bioactive compounds were detected within the essential oil profiles of control and carrageenan-treated specimens, respectively. The proportions of necrotic and apoptotic HEK-293 and HT-29 cells were diminished following co-treatment with AFB1 and the carrageenan-treated M. officinalis essential oil. Furthermore, the mRNA expression levels of caspase-3, caspase-9, and Bax were found to be elevated in both HT-29 and HEK-293 cells exposed to AFB1, whereas the expression of Bcl-2 and NF-κB genes was reduced compared to the control group. These gene expression changes were reversed by co-treatment with carrageenan-treated M. officinalis essential oil and AFB1. Additionally, AFB1 was observed to induce reactive oxygen species (ROS) in both HT-29 and HEK-293 cells; however, treatment with carrageenan-treated M. officinalis essential oil resulted in a decrease in ROS levels within cells subjected to AFB1 contamination.</p><p><strong>Discussion: </strong>The findings demonstrated that carrageenan treatment increases the overall content of the essential oil in M. officinalis. HT29 cells serve as a human colorectal epithelial (adenocarcinoma) model, frequently utilized in in vitro investigations of mycotoxins, thereby effectively simulating the intestinal and colorectal environment associated with dietary exposure to AFB1. The investigation into the mechanisms by which enhanced M. officinalis essential oil mitigates AFB1-in
{"title":"Effects of enhanced Melissa officinalis essential oil via carrageenan on mitigating aflatoxin b1-induced cytotoxicity in HT-29 and HEK-293 cells.","authors":"Malihe Ganjali, Maryam Rahimi, Dariush Ramezan, Zeynab Mohkami, Ali Ghorbani Ranjbary, Ahad Yamchi","doi":"10.1186/s12906-025-05228-8","DOIUrl":"https://doi.org/10.1186/s12906-025-05228-8","url":null,"abstract":"<p><strong>Background: </strong>Aflatoxin B1 (AFB1) is a common contaminant in agricultural and animal-derived products worldwide, representing a significant environmental hazard. Therefore, this study aimed to assess the anti-toxicity effects of enhanced essential oil from Melissa officinalis, through a safe carrageenan, on HT-29 and HEK-293 cells contaminated with AFB1.</p><p><strong>Methods: </strong>Seeds of M. officinalis were cultivated in plastic containers and subsequently treated with 400 ppm carrageenan during the 6-8 leaf developmental stage. Gas chromatography-mass spectrometry (GC/MS) was employed to characterize the bioactive compounds of the essential oil. The cancerous HT-29 and healthy HEK-293 cell lines were exposed to various concentrations of AFB1 (0.5-3 µg/mL), with and without carrageenan-treated M. officinalis essential oil extract at concentrations ranging from 5 to 40 µg/mL. Based on the findings from the MTT assay, 1 µg/mL of AFB1 and 10 µg/mL of the essential oil extract were selected for subsequent analyses, including flow cytometry, reactive oxygen species assessments, and RT-qPCR.</p><p><strong>Results: </strong>Flow cytometric analysis indicated that AFB1-induced necrosis in healthy HEK-293 cells (13.10%) was significantly greater than in HT-29 cancer cells (2.33%). In contrast, AFB1 elicited a greater degree of early apoptosis (14.80%) and late apoptosis (11.20%) in HT-29 cells compared to HEK-293 cells, which demonstrated 3.86% and 2.26% early and late apoptosis, respectively. A total of nine and fourteen bioactive compounds were detected within the essential oil profiles of control and carrageenan-treated specimens, respectively. The proportions of necrotic and apoptotic HEK-293 and HT-29 cells were diminished following co-treatment with AFB1 and the carrageenan-treated M. officinalis essential oil. Furthermore, the mRNA expression levels of caspase-3, caspase-9, and Bax were found to be elevated in both HT-29 and HEK-293 cells exposed to AFB1, whereas the expression of Bcl-2 and NF-κB genes was reduced compared to the control group. These gene expression changes were reversed by co-treatment with carrageenan-treated M. officinalis essential oil and AFB1. Additionally, AFB1 was observed to induce reactive oxygen species (ROS) in both HT-29 and HEK-293 cells; however, treatment with carrageenan-treated M. officinalis essential oil resulted in a decrease in ROS levels within cells subjected to AFB1 contamination.</p><p><strong>Discussion: </strong>The findings demonstrated that carrageenan treatment increases the overall content of the essential oil in M. officinalis. HT29 cells serve as a human colorectal epithelial (adenocarcinoma) model, frequently utilized in in vitro investigations of mycotoxins, thereby effectively simulating the intestinal and colorectal environment associated with dietary exposure to AFB1. The investigation into the mechanisms by which enhanced M. officinalis essential oil mitigates AFB1-in","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145846355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-24DOI: 10.1186/s12906-025-05151-y
Agnete Egilsdatter Kristoffersen, Trine Stub
{"title":"Trends in prevalence and associations of complementary and alternative medicine use in Norway 2012-2024: Insights from seven biennial cross-sectional studies.","authors":"Agnete Egilsdatter Kristoffersen, Trine Stub","doi":"10.1186/s12906-025-05151-y","DOIUrl":"10.1186/s12906-025-05151-y","url":null,"abstract":"","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"444"},"PeriodicalIF":3.4,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12729212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145826822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}